Last reviewed · How we verify
NCT03113305
Changes in Ingestive Behaviour Following Gastric Bypass
trial in Morbid Obesity in 63 participants. Completed in 31 May 2023.
31 May 2023
Quick facts
| Lead sponsor | University of Ulster |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 63 |
| Start date | 1 September 2016 |
| Primary completion | 31 May 2023 |
| Estimated completion | 31 May 2023 |
| Sites | 2 locations across United Kingdom, Ireland |
Conditions studied
- Morbid Obesity — all drugs for Morbid Obesity →
Sponsor
University of Ulster
Who can join
18 and older, any sex, with Morbid Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The gastric bypass procedure is known to be one of the most successful treatments for morbid obesity and Type 2 diabetes mellitus, and has been shown to decrease appetite, energy intake, body weight and glycemia both in the short and long term. A number of reports hypothesise that these changes may be driven, at least in part, by positive shifts in food preferences following surgery. However, findings are drawn from self-reported dietary intakes which are beset with measurement bias, thus precluding definite conclusions. The current work aims to directly observe food intake to test the hypothesis that after gastric bypass food intake changes in a manner which leads to beneficial outcomes on body weight when compared to weight stable control participants. Patients (n=32) with a planned gastric bypass procedure will be recruited from Phoenix Health (Ireland and England) and Letterkenny University Hospital (Ireland), alongside control participants (n=32) with no planned weight loss. All subjects will attend the Human Intervention Studies Unit (HISU), Ulster University on five occasions (1-month pre-surgery and 3, 12, 24 and 60 months post-surgery, with controls being time-matched). Study visits will be fully residential involving two overnight stays within the facility during which participants' 24-hour food intake will be covertly measured (7am-11pm Day 2 and breakfast Day 3) and the following procedures undertaken; basal metabolic rate, body composition, bone health, assessment of liking/wanting high fat foods and post-meal gut hormone responses. On each study visit participants will have ad lib access to a range of foods of varying macronutrient composition and which are compatible with their stated food preferences (assessed prior to the start of the study). Changes in all ingestive behaviours will be evaluated over time as compared to the control participants.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Food Intake Following Gastric Bypass Surgery: Patients Eat Less but Do Not Eat Differently.
Livingstone MBE, Redpath T, Naseer F, Boyd A, et al · · 2022 · cited 26× · PMID 36774099 · DOI 10.1093/jn/nxac164 -
Metabolic adaptation following gastric bypass surgery: results from a 2-year observational study.
Naseer F, Zhang SD, Miras AD, Redpath T, et al · · 2024 · cited 6× · PMID 39227457 · DOI 10.1038/s41366-024-01585-5 -
Evaluation of the impact of gastric bypass surgery on eating behaviour using objective methodologies under residential conditions: Rationale and study protocol.
Redpath T, Naseer F, Price RK, Boyd A, et al · · 2021 · cited 5× · PMID 34646959 · DOI 10.1016/j.conctc.2021.100846 -
Metabolic adaptation following gastric bypass surgery: Results from a 2-year observational study.
Price R, Naseer F, Zhang S, Miras A, et al · · 2024 · DOI 10.21203/rs.3.rs-3789295/v1
Verify or expand the search:
- PubMed search for NCT03113305
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Morbid Obesity
Currently open trials in the same condition.
- NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
- NCT06413264 — Ultrasonography Guided Pneumoperitoneum for Laparoscopic Surgery in Morbidly Obese Patients · NA · recruiting
- NCT07289555 — Tailored Stapled SADI-S: Initial Report and Preliminary Results · NA · recruiting
- NCT07263269 — Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in · NA · active not recruiting
- NCT06293703 — Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study) · NA · recruiting
Other University of Ulster trials
Trials by the same sponsor.
- NCT07253155 — Probiotics Use and Preventing Gastrointestinal Symptoms in People Living With Overweight and Obesity. · NA · enrolling by invitation
- NCT06667505 — To Test an e-Health Educational Intervention Patients With an ICD · NA · recruiting
- NCT06945003 — Study of Exercise Capacity and Physical Activity in Children With Congenital Heart Disease · NA · not yet recruiting
- NCT06914804 — Stomasense: A New Route to the Proactive Detection and Management of Leaks Within Ostomy Pouches · NA · enrolling by invitation
- NCT06921811 — Bioavailability From Chickpea Meals in Ileostomists? · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03113305 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Ulster
- Last refreshed: 29 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03113305.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing